Summary & Overview
HCPCS J0463: Atropine Sulfate Injection, 0.01 mg
HCPCS Level II code J0463 denotes a unit of atropine sulfate injection (Fresenius and therapeutically equivalent), 0.01 mg. The code captures billing for parenteral administration of a potent anticholinergic used primarily in emergency medicine, anesthesia, and certain acute care procedures. Nationally, this code matters because it standardizes reporting and reimbursement for a high-acuity medication that is frequently used in time-sensitive clinical scenarios such as bradycardia management and organophosphate poisoning.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on clinical context and typical sites of service, followed by benchmarks and payer-specific coverage patterns where available. The publication outlines common billing considerations tied to HCPCS Level II code J0463, summarizes typical use cases in hospital and emergency settings, and highlights any national-level policy updates or coding guidance relevant to parenteral atropine.
This executive summary is intended for clinicians, billing professionals, and policy analysts seeking an authoritative reference on the code’s clinical role, where it is typically billed, and which major payers' coverage environments are addressed in the full publication. Data not provided in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code J0463 represents an injection of atropine sulfate (Fresenius and therapeutically equivalent), dosed at 0.01 mg per unit. This code denotes a pharmaceutical administration event for a concentrated anticholinergic agent commonly used in emergency and perioperative care.
Service type: Medication injection (parenteral drug administration)
Typical site of service: Hospital inpatient and emergency department settings, surgical suites, and other acute care locations where parenteral medications are administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to the emergency department, preoperative holding area, or outpatient clinic with symptomatic bradycardia or organophosphate poisoning requiring anticholinergic therapy. A clinician (emergency physician, anesthesiologist, or critical care nurse under protocol) determines the need for parenteral atropine sulfate and obtains IV access. The ordered dose is calculated by weight and clinical indication; a pharmacy or medication cart supplies J0463–equivalent vials (atropine sulfate 0.01 mg per billing unit). The provider documents the indication, dose administered, route (intravenous or intramuscular), time, lot number, and patient response. Typical workflow steps: medication order entry, dose verification by nursing, administration with vital sign monitoring, documentation in the chart, and billing using J0463 with appropriate modifiers when required. The typical site of service is the emergency department, inpatient hospital bed, or perioperative/preoperative holding area.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day | Use when an E/M visit is distinct from the administration of J0463 and must be reported separately. |